Found 49 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50276625
(1-Adamantan-1-yl-3-[3-(3-morpholin-4-yl-propoxy)-p...)Show SMILES O=C(Nc1cccc(OCCCN2CCOCC2)c1)NC12CC3CC(CC(C3)C1)C2 |TLB:19:20:23:27.26.25,THB:21:22:25:29.20.28,21:20:23.22.27:25,28:20:23:27.26.25,28:26:23:29.21.20| Show InChI InChI=1S/C24H35N3O3/c28-23(26-24-15-18-11-19(16-24)13-20(12-18)17-24)25-21-3-1-4-22(14-21)30-8-2-5-27-6-9-29-10-7-27/h1,3-4,14,18-20H,2,5-13,15-17H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296224
(1-(4-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)Show SMILES FC(F)(F)Oc1ccc(NC(=O)Nc2ccc(OCCCN3CCOCC3)cc2)cc1 Show InChI InChI=1S/C21H24F3N3O4/c22-21(23,24)31-19-8-4-17(5-9-19)26-20(28)25-16-2-6-18(7-3-16)30-13-1-10-27-11-14-29-15-12-27/h2-9H,1,10-15H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296223
(1-(4-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)Show SMILES FC(F)(F)c1ccc(NC(=O)Nc2ccc(OCCCN3CCOCC3)cc2)cc1 Show InChI InChI=1S/C21H24F3N3O3/c22-21(23,24)16-2-4-17(5-3-16)25-20(28)26-18-6-8-19(9-7-18)30-13-1-10-27-11-14-29-15-12-27/h2-9H,1,10-15H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296210
(1-Adamantan-1-yl-3-[4-fluoro-3-(3-morpholin-4-yl-p...)Show SMILES Fc1ccc(NC(=O)NC23CC4CC(CC(C4)C2)C3)cc1OCCCN1CCOCC1 |TLB:8:9:12:16.15.14,THB:10:11:14:18.9.17,10:9:12.11.16:14,17:9:12:16.15.14,17:15:12:18.10.9| Show InChI InChI=1S/C24H34FN3O3/c25-21-3-2-20(13-22(21)31-7-1-4-28-5-8-30-9-6-28)26-23(29)27-24-14-17-10-18(15-24)12-19(11-17)16-24/h2-3,13,17-19H,1,4-12,14-16H2,(H2,26,27,29) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296214
(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-(4-(t...)Show SMILES Fc1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1OCCCN1CCOCC1 Show InChI InChI=1S/C21H23F4N3O4/c22-18-7-4-16(14-19(18)31-11-1-8-28-9-12-30-13-10-28)27-20(29)26-15-2-5-17(6-3-15)32-21(23,24)25/h2-7,14H,1,8-13H2,(H2,26,27,29) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50276673
(1-(3-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)Show SMILES FC(F)(F)c1ccc(NC(=O)Nc2cccc(OCCCN3CCOCC3)c2)cc1 Show InChI InChI=1S/C21H24F3N3O3/c22-21(23,24)16-5-7-17(8-6-16)25-20(28)26-18-3-1-4-19(15-18)30-12-2-9-27-10-13-29-14-11-27/h1,3-8,15H,2,9-14H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296226
(2-Adamantan-1-yl-N-[4-(3-morpholin-4-yl-propoxy)-p...)Show SMILES O=C(CC12CC3CC(CC(C3)C1)C2)Nc1ccc(OCCCN2CCOCC2)cc1 |TLB:2:3:6:10.9.8,THB:4:5:8:12.3.11,4:3:6.5.10:8,11:3:6:10.9.8,11:9:6:12.4.3| Show InChI InChI=1S/C25H36N2O3/c28-24(18-25-15-19-12-20(16-25)14-21(13-19)17-25)26-22-2-4-23(5-3-22)30-9-1-6-27-7-10-29-11-8-27/h2-5,19-21H,1,6-18H2,(H,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296213
(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-(4-(t...)Show SMILES Fc1ccc(NC(=O)Nc2ccc(cc2)C(F)(F)F)cc1OCCCN1CCOCC1 Show InChI InChI=1S/C21H23F4N3O3/c22-18-7-6-17(14-19(18)31-11-1-8-28-9-12-30-13-10-28)27-20(29)26-16-4-2-15(3-5-16)21(23,24)25/h2-7,14H,1,8-13H2,(H2,26,27,29) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50223389
(1-Adamantan-1-yl-3-[4-(3-morpholin-4-yl-propoxy)-p...)Show SMILES O=C(Nc1ccc(OCCCN2CCOCC2)cc1)NC12CC3CC(CC(C3)C1)C2 |TLB:19:20:23.22.27:25,THB:21:22:25:29.20.28,21:20:23.22.27:25,28:20:23:27.26.25,28:26:23:29.21.20,19:20:23:27.26.25| Show InChI InChI=1S/C24H35N3O3/c28-23(26-24-15-18-12-19(16-24)14-20(13-18)17-24)25-21-2-4-22(5-3-21)30-9-1-6-27-7-10-29-11-8-27/h2-5,18-20H,1,6-17H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296225
(1-(4-chlorophenyl)-3-(4-(3-morpholinopropoxy)pheny...)Show InChI InChI=1S/C20H24ClN3O3/c21-16-2-4-17(5-3-16)22-20(25)23-18-6-8-19(9-7-18)27-13-1-10-24-11-14-26-15-12-24/h2-9H,1,10-15H2,(H2,22,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296197
(1-(4-chlorophenyl)-3-(3-(3-morpholinopropoxy)pheny...)Show InChI InChI=1S/C20H24ClN3O3/c21-16-5-7-17(8-6-16)22-20(25)23-18-3-1-4-19(15-18)27-12-2-9-24-10-13-26-14-11-24/h1,3-8,15H,2,9-14H2,(H2,22,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296219
(1-Adamantan-1-yl-3-[3-(3-morpholin-4-yl-propoxy)-c...)Show SMILES O=C(NC1CCCC(C1)OCCCN1CCOCC1)NC12CC3CC(CC(C3)C1)C2 |TLB:19:20:23:27.26.25,THB:21:22:25:29.20.28,21:20:23.22.27:25,28:20:23:27.26.25,28:26:23:29.21.20| Show InChI InChI=1S/C24H41N3O3/c28-23(26-24-15-18-11-19(16-24)13-20(12-18)17-24)25-21-3-1-4-22(14-21)30-8-2-5-27-6-9-29-10-7-27/h18-22H,1-17H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50276676
(2-Adamantan-1-yl-N-[3-(3-morpholin-4-yl-propoxy)-p...)Show SMILES O=C(CC12CC3CC(CC(C3)C1)C2)Nc1cccc(OCCCN2CCOCC2)c1 |TLB:2:3:6:10.9.8,THB:4:5:8:12.3.11,4:3:6.5.10:8,11:3:6:10.9.8,11:9:6:12.4.3| Show InChI InChI=1S/C25H36N2O3/c28-24(18-25-15-19-11-20(16-25)13-21(12-19)17-25)26-22-3-1-4-23(14-22)30-8-2-5-27-6-9-29-10-7-27/h1,3-4,14,19-21H,2,5-13,15-18H2,(H,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50276626
(1-cyclohexyl-3-(3-(3-morpholinopropoxy)phenyl)urea...)Show InChI InChI=1S/C20H31N3O3/c24-20(21-17-6-2-1-3-7-17)22-18-8-4-9-19(16-18)26-13-5-10-23-11-14-25-15-12-23/h4,8-9,16-17H,1-3,5-7,10-15H2,(H2,21,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296215
(1-(4-chlorophenyl)-3-(4-fluoro-3-(3-morpholinoprop...)Show InChI InChI=1S/C20H23ClFN3O3/c21-15-2-4-16(5-3-15)23-20(26)24-17-6-7-18(22)19(14-17)28-11-1-8-25-9-12-27-13-10-25/h2-7,14H,1,8-13H2,(H2,23,24,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296220
(2-Adamantan-1-yl-N-[3-(3-morpholin-4-yl-propoxy)-c...)Show SMILES O=C(CC12CC3CC(CC(C3)C1)C2)NC1CCCC(C1)OCCCN1CCOCC1 |TLB:2:3:6:10.9.8,THB:4:5:8:12.3.11,4:3:6.5.10:8,11:3:6:10.9.8,11:9:6:12.4.3| Show InChI InChI=1S/C25H42N2O3/c28-24(18-25-15-19-11-20(16-25)13-21(12-19)17-25)26-22-3-1-4-23(14-22)30-8-2-5-27-6-9-29-10-7-27/h19-23H,1-18H2,(H,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 5.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296221
(1-cyclohexyl-3-(4-(3-morpholinopropoxy)phenyl)urea...)Show InChI InChI=1S/C20H31N3O3/c24-20(21-17-5-2-1-3-6-17)22-18-7-9-19(10-8-18)26-14-4-11-23-12-15-25-16-13-23/h7-10,17H,1-6,11-16H2,(H2,21,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296209
(1-cyclohexyl-3-(4-fluoro-3-(3-morpholinopropoxy)ph...)Show InChI InChI=1S/C20H30FN3O3/c21-18-8-7-17(23-20(25)22-16-5-2-1-3-6-16)15-19(18)27-12-4-9-24-10-13-26-14-11-24/h7-8,15-16H,1-6,9-14H2,(H2,22,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296216
(2-Adamantan-1-yl-N-[4-fluoro-3-(3-morpholin-4-yl-p...)Show SMILES Fc1ccc(NC(=O)CC23CC4CC(CC(C4)C2)C3)cc1OCCCN1CCOCC1 |TLB:8:9:12:16.15.14,THB:10:11:14:18.9.17,10:9:12.11.16:14,17:9:12:16.15.14,17:15:12:18.10.9| Show InChI InChI=1S/C25H35FN2O3/c26-22-3-2-21(13-23(22)31-7-1-4-28-5-8-30-9-6-28)27-24(29)17-25-14-18-10-19(15-25)12-20(11-18)16-25/h2-3,13,18-20H,1,4-12,14-17H2,(H,27,29) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 6.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50276674
(1-(3-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)Show SMILES FC(F)(F)Oc1ccc(NC(=O)Nc2cccc(OCCCN3CCOCC3)c2)cc1 Show InChI InChI=1S/C21H24F3N3O4/c22-21(23,24)31-18-7-5-16(6-8-18)25-20(28)26-17-3-1-4-19(15-17)30-12-2-9-27-10-13-29-14-11-27/h1,3-8,15H,2,9-14H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296193
(1-(3,4-difluorophenyl)-3-(3-(3-morpholinopropoxy)p...)Show InChI InChI=1S/C20H23F2N3O3/c21-18-6-5-16(14-19(18)22)24-20(26)23-15-3-1-4-17(13-15)28-10-2-7-25-8-11-27-12-9-25/h1,3-6,13-14H,2,7-12H2,(H2,23,24,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296196
(1-(3-(3-morpholinopropoxy)phenyl)-3-(3-(trifluorom...)Show SMILES FC(F)(F)c1cccc(NC(=O)Nc2cccc(OCCCN3CCOCC3)c2)c1 Show InChI InChI=1S/C21H24F3N3O3/c22-21(23,24)16-4-1-5-17(14-16)25-20(28)26-18-6-2-7-19(15-18)30-11-3-8-27-9-12-29-13-10-27/h1-2,4-7,14-15H,3,8-13H2,(H2,25,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 13.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296192
(1-(4-fluorophenyl)-3-(3-(3-morpholinopropoxy)pheny...)Show InChI InChI=1S/C20H24FN3O3/c21-16-5-7-17(8-6-16)22-20(25)23-18-3-1-4-19(15-18)27-12-2-9-24-10-13-26-14-11-24/h1,3-8,15H,2,9-14H2,(H2,22,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50276725
(2-cyclohexyl-N-(3-(3-morpholinopropoxy)phenyl)acet...)Show InChI InChI=1S/C21H32N2O3/c24-21(16-18-6-2-1-3-7-18)22-19-8-4-9-20(17-19)26-13-5-10-23-11-14-25-15-12-23/h4,8-9,17-18H,1-3,5-7,10-16H2,(H,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296199
(1-(benzo[d][1,3]dioxol-5-yl)-3-(3-(3-morpholinopro...)Show InChI InChI=1S/C21H25N3O5/c25-21(23-17-5-6-19-20(14-17)29-15-28-19)22-16-3-1-4-18(13-16)27-10-2-7-24-8-11-26-12-9-24/h1,3-6,13-14H,2,7-12,15H2,(H2,22,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296191
(1-(3-(3-morpholinopropoxy)phenyl)-3-phenylurea | C...)Show InChI InChI=1S/C20H25N3O3/c24-20(21-17-6-2-1-3-7-17)22-18-8-4-9-19(16-18)26-13-5-10-23-11-14-25-15-12-23/h1-4,6-9,16H,5,10-15H2,(H2,21,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296222
(1-(4-(3-morpholinopropoxy)phenyl)-3-phenylurea | C...)Show InChI InChI=1S/C20H25N3O3/c24-20(21-17-5-2-1-3-6-17)22-18-7-9-19(10-8-18)26-14-4-11-23-12-15-25-16-13-23/h1-3,5-10H,4,11-16H2,(H2,21,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296212
(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-(4-fl...)Show SMILES Fc1ccc(NC(=O)Nc2ccc(F)c(OCCCN3CCOCC3)c2)cc1 Show InChI InChI=1S/C20H23F2N3O3/c21-15-2-4-16(5-3-15)23-20(26)24-17-6-7-18(22)19(14-17)28-11-1-8-25-9-12-27-13-10-25/h2-7,14H,1,8-13H2,(H2,23,24,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296229
(CHEMBL557240 | N-(4-(3-morpholinopropoxy)phenyl)-2...)Show SMILES FC(F)(F)Oc1ccc(CC(=O)Nc2ccc(OCCCN3CCOCC3)cc2)cc1 Show InChI InChI=1S/C22H25F3N2O4/c23-22(24,25)31-20-6-2-17(3-7-20)16-21(28)26-18-4-8-19(9-5-18)30-13-1-10-27-11-14-29-15-12-27/h2-9H,1,10-16H2,(H,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296205
(CHEMBL561522 | N-(3-(3-morpholinopropoxy)phenyl)-2...)Show SMILES FC(F)(F)Oc1ccc(CC(=O)Nc2cccc(OCCCN3CCOCC3)c2)cc1 Show InChI InChI=1S/C22H25F3N2O4/c23-22(24,25)31-19-7-5-17(6-8-19)15-21(28)26-18-3-1-4-20(16-18)30-12-2-9-27-10-13-29-14-11-27/h1,3-8,16H,2,9-15H2,(H,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296228
(CHEMBL557038 | N-(4-(3-morpholinopropoxy)phenyl)-2...)Show SMILES FC(F)(F)c1ccc(CC(=O)Nc2ccc(OCCCN3CCOCC3)cc2)cc1 Show InChI InChI=1S/C22H25F3N2O3/c23-22(24,25)18-4-2-17(3-5-18)16-21(28)26-19-6-8-20(9-7-19)30-13-1-10-27-11-14-29-15-12-27/h2-9H,1,10-16H2,(H,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50276727
(CHEMBL459778 | N-(3-(3-morpholinopropoxy)phenyl)-2...)Show SMILES FC(F)(F)c1ccc(CC(=O)Nc2cccc(OCCCN3CCOCC3)c2)cc1 Show InChI InChI=1S/C22H25F3N2O3/c23-22(24,25)18-7-5-17(6-8-18)15-21(28)26-19-3-1-4-20(16-19)30-12-2-9-27-10-13-29-14-11-27/h1,3-8,16H,2,9-15H2,(H,26,28) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296211
(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-pheny...)Show InChI InChI=1S/C20H24FN3O3/c21-18-8-7-17(23-20(25)22-16-5-2-1-3-6-16)15-19(18)27-12-4-9-24-10-13-26-14-11-24/h1-3,5-8,15H,4,9-14H2,(H2,22,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296206
(2-(4-chlorophenyl)-N-(3-(3-morpholinopropoxy)pheny...)Show InChI InChI=1S/C21H25ClN2O3/c22-18-7-5-17(6-8-18)15-21(25)23-19-3-1-4-20(16-19)27-12-2-9-24-10-13-26-14-11-24/h1,3-8,16H,2,9-15H2,(H,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 116 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296194
(1-(2,4-difluorophenyl)-3-(3-(3-morpholinopropoxy)p...)Show SMILES Fc1ccc(NC(=O)Nc2cccc(OCCCN3CCOCC3)c2)c(F)c1 Show InChI InChI=1S/C20H23F2N3O3/c21-15-5-6-19(18(22)13-15)24-20(26)23-16-3-1-4-17(14-16)28-10-2-7-25-8-11-27-12-9-25/h1,3-6,13-14H,2,7-12H2,(H2,23,24,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 121 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296230
(2-(4-chlorophenyl)-N-(4-(3-morpholinopropoxy)pheny...)Show InChI InChI=1S/C21H25ClN2O3/c22-18-4-2-17(3-5-18)16-21(25)23-19-6-8-20(9-7-19)27-13-1-10-24-11-14-26-15-12-24/h2-9H,1,10-16H2,(H,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296218
(CHEMBL561664 | N-(4-fluoro-3-(3-morpholinopropoxy)...)Show SMILES Fc1ccc(NC(=O)Cc2ccc(OC(F)(F)F)cc2)cc1OCCCN1CCOCC1 Show InChI InChI=1S/C22H24F4N2O4/c23-19-7-4-17(15-20(19)31-11-1-8-28-9-12-30-13-10-28)27-21(29)14-16-2-5-18(6-3-16)32-22(24,25)26/h2-7,15H,1,8-14H2,(H,27,29) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 145 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296217
(CHEMBL564986 | N-(4-fluoro-3-(3-morpholinopropoxy)...)Show SMILES Fc1ccc(NC(=O)Cc2ccc(cc2)C(F)(F)F)cc1OCCCN1CCOCC1 Show InChI InChI=1S/C22H24F4N2O3/c23-19-7-6-18(15-20(19)31-11-1-8-28-9-12-30-13-10-28)27-21(29)14-16-2-4-17(5-3-16)22(24,25)26/h2-7,15H,1,8-14H2,(H,27,29) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 156 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296200
(1-(3-(dimethylamino)phenyl)-3-(3-(3-morpholinoprop...)Show SMILES CN(C)c1cccc(NC(=O)Nc2cccc(OCCCN3CCOCC3)c2)c1 Show InChI InChI=1S/C22H30N4O3/c1-25(2)20-8-3-6-18(16-20)23-22(27)24-19-7-4-9-21(17-19)29-13-5-10-26-11-14-28-15-12-26/h3-4,6-9,16-17H,5,10-15H2,1-2H3,(H2,23,24,27) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296204
(2-(3,4-difluorophenyl)-N-(3-(3-morpholinopropoxy)p...)Show InChI InChI=1S/C21H24F2N2O3/c22-19-6-5-16(13-20(19)23)14-21(26)24-17-3-1-4-18(15-17)28-10-2-7-25-8-11-27-12-9-25/h1,3-6,13,15H,2,7-12,14H2,(H,24,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 321 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296208
(2-(benzo[d][1,3]dioxol-5-yl)-N-(3-(3-morpholinopro...)Show InChI InChI=1S/C22H26N2O5/c25-22(14-17-5-6-20-21(13-17)29-16-28-20)23-18-3-1-4-19(15-18)27-10-2-7-24-8-11-26-12-9-24/h1,3-6,13,15H,2,7-12,14,16H2,(H,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 365 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296203
(2-(4-fluorophenyl)-N-(3-(3-morpholinopropoxy)pheny...)Show InChI InChI=1S/C21H25FN2O3/c22-18-7-5-17(6-8-18)15-21(25)23-19-3-1-4-20(16-19)27-12-2-9-24-10-13-26-14-11-24/h1,3-8,16H,2,9-15H2,(H,23,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296227
(CHEMBL557037 | N-(4-(3-morpholinopropoxy)phenyl)-2...)Show InChI InChI=1S/C21H26N2O3/c24-21(17-18-5-2-1-3-6-18)22-19-7-9-20(10-8-19)26-14-4-11-23-12-15-25-16-13-23/h1-3,5-10H,4,11-17H2,(H,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 870 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296190
(1-tert-butyl-3-(3-(3-morpholinopropoxy)phenyl)urea...)Show InChI InChI=1S/C18H29N3O3/c1-18(2,3)20-17(22)19-15-6-4-7-16(14-15)24-11-5-8-21-9-12-23-13-10-21/h4,6-7,14H,5,8-13H2,1-3H3,(H2,19,20,22) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296202
(3,3-dimethyl-N-(3-(3-morpholinopropoxy)phenyl)buta...)Show InChI InChI=1S/C19H30N2O3/c1-19(2,3)15-18(22)20-16-6-4-7-17(14-16)24-11-5-8-21-9-12-23-13-10-21/h4,6-7,14H,5,8-13,15H2,1-3H3,(H,20,22) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296195
(1-(3-(3-morpholinopropoxy)phenyl)-3-(2,4,6-trifluo...)Show SMILES Fc1cc(F)c(NC(=O)Nc2cccc(OCCCN3CCOCC3)c2)c(F)c1 Show InChI InChI=1S/C20H22F3N3O3/c21-14-11-17(22)19(18(23)12-14)25-20(27)24-15-3-1-4-16(13-15)29-8-2-5-26-6-9-28-10-7-26/h1,3-4,11-13H,2,5-10H2,(H2,24,25,27) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.88E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296201
(1-(3-(3-morpholinopropoxy)phenyl)-3-(pyridin-3-yl)...)Show InChI InChI=1S/C19H24N4O3/c24-19(22-17-5-2-7-20-15-17)21-16-4-1-6-18(14-16)26-11-3-8-23-9-12-25-13-10-23/h1-2,4-7,14-15H,3,8-13H2,(H2,21,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296198
(1-(2,6-dichlorophenyl)-3-(3-(3-morpholinopropoxy)p...)Show SMILES Clc1cccc(Cl)c1NC(=O)Nc1cccc(OCCCN2CCOCC2)c1 Show InChI InChI=1S/C20H23Cl2N3O3/c21-17-6-2-7-18(22)19(17)24-20(26)23-15-4-1-5-16(14-15)28-11-3-8-25-9-12-27-13-10-25/h1-2,4-7,14H,3,8-13H2,(H2,23,24,26) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Bifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50296207
(CHEMBL551396 | N-(3-(3-morpholinopropoxy)phenyl)-2...)Show InChI InChI=1S/C20H25N3O3/c24-20(14-17-4-2-7-21-16-17)22-18-5-1-6-19(15-18)26-11-3-8-23-9-12-25-13-10-23/h1-2,4-7,15-16H,3,8-14H2,(H,22,24) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Arete Therapeutics, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assay |
Bioorg Med Chem Lett 19: 4259-63 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.102
BindingDB Entry DOI: 10.7270/Q2VQ32Q0 |
More data for this
Ligand-Target Pair | |
Search and Browse
